1250mg Niclosamide Bolus kubwinka
.png)
.png)
.png)
.png)
Ibigize
Buri bolus irimo:
Niclosamide: 1250mg.
Farumasi nuburozi
Iki gicuruzwa kirashobora kubuza okiside fosifora ya mitochondriya muri selile tapeworm.Iyo yibanze cyane, irashobora kubuza guhumeka umubiri winyo kandi ikabuza gufata glucose, bityo bigatuma yangirika.Umuti urashobora gusenya umutwe nigice cyimbere cyigice cyumubiri, kandi igice cyacyo kigahinduka kandi bigoye kumenya igihe gisohotse.Iki gicuruzwa nta ngaruka zica ku magi.
Ibyerekana
Niclosamide bolus ikoreshwa mu kwanduza inyamaswa.Numuti mwiza wo kuvura Taenia saginata, Hymenoderma brevisiae, Schizocephala latifolia nizindi ndwara.Ifite kandi akamaro kurwanya Taenia solium, ariko irashobora kongera amahirwe yo kwandura cysticercose nyuma yo gufata imiti.
Intama n'ihene:
Moniezia spp., Stilesia spp., Avitellina spp.n'amara adakuze Paramphistomiasis spp.murwego rwabana bato. (intambwe yo mara)
Imbwa n'injangwe:Taenia spp., Dipylidium caninum, Echinococcus granulosus (by'agateganyo).
Imikoreshereze & Ubuyobozi
Nubuyobozi bwo mu kanwa:
Intama n'ihene: 75 - 80 mg ya Niclosamide kuri kg Ibiro biremereye cyangwa bolus imwe kuri 15 kg Uburemere.
Inka: 60 - 65 mg ya Niclosamide kuri kg Ibiro biremereye cyangwa bolus imwe kuri 20 kg Uburemere
Imbwa: 125 mg ya Niclosamide kuri kg Ibiro biremereye cyangwa bolus imwe kuri kg 10 Uburemere
Injangwe: mg 125 za Niclosamide kuri kg Ibiro biremereye cyangwa 1/3 bolus kuri kg 3.3
Kwirinda
Intama n'ihene birashobora guhinduka ubutayu butazakoreshwa mu kurisha mu byumweru biri imbere nyuma yo kuvurwa, kandi bukaba buhura n’izuba ryinshi ry’intama zanduye, intama n’umwaka bigomba kuvurwa mbere na mbere.Mu nka, muri rusange birakenewe kuvura inyamaswa zikiri nto kugeza kumezi 6-8, kuko abakuze bazagira ubudahangarwa nyuma yiki gihe.Niclosam irashobora gukoreshwa mubikoko bitwite.Niclosam ntigomba gukoreshwa imbere ya Atoniya yo munda kugirango hirindwe ibyago byo kwangirika kwangirika kwinzoka zishe.
Ibihe byo gukuramo
Intama: iminsi 28.
Inka: iminsi 28.
Ububiko
Bika ahantu hakonje.Rinda urumuri
Ntukagere kubana.
Hebei Veyong pharmaceutical Co., Ltd yashinzwe mu 2002, iherereye mu mujyi wa Shijiazhuang, Intara ya Hebei, mu Bushinwa, iruhande rw’umurwa mukuru wa Beijing.Ni ikigo kinini cyemewe na GMP cyemewe n’ibiyobyabwenge, hamwe na R&D, gukora no kugurisha amatungo ya APIs, imyiteguro, ibiryo byateganijwe hamwe ninyongeramusaruro.Nka Centre Tekinike yintara, Veyong yashyizeho uburyo bushya bwa R&D kumiti yubuvuzi bwamatungo, kandi nicyo kigo kizwi cyane mu guhanga udushya mu ikoranabuhanga rishingiye ku buvuzi bw’amatungo, hari abahanga mu bya tekinike 65.Veyong ifite ibishingwe bibiri: Shijiazhuang na Ordos, muri byo ikigo cya Shijiazhuang gifite ubuso bwa m2 78,706 m2, hamwe n’ibicuruzwa 13 bya API birimo Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, n'imirongo 11 yo gutegura harimo gutera inshinge, igisubizo cyo mu kanwa, ifu , premix, bolus, imiti yica udukoko hamwe na disinfectant, ects.Veyong itanga APIs, zirenga 100 bwite- label itegura, na serivisi ya OEM & ODM.
Veyong yita cyane ku micungire ya sisitemu ya EHS (Ibidukikije, Ubuzima & Umutekano), kandi yabonye impamyabumenyi ya ISO14001 na OHSAS18001.Veyong yashyizwe ku rutonde rw’inganda zigenda ziyongera mu Ntara ya Hebei kandi irashobora gutanga ibicuruzwa bikomeza.
Veyong yashyizeho uburyo bwuzuye bwo gucunga neza, yabonye icyemezo cya ISO9001, icyemezo cya GMP mu Bushinwa, icyemezo cya Ositarariya APVMA GMP, icyemezo cya Etiyopiya GMP, icyemezo cya Ivermectin CEP, kandi yatsinze igenzura rya FDA muri Amerika.Veyong ifite itsinda ryumwuga ryo kwiyandikisha, kugurisha na serivisi ya tekiniki, isosiyete yacu imaze kwiringira no gushyigikirwa nabakiriya benshi kubwiza bwibicuruzwa byiza, ubuziranenge bwiza mbere yo kugurisha na nyuma yo kugurisha, gucunga neza na siyansi.Veyong yakoze ubufatanye burambye n’inganda nyinshi zizwi cyane mu bya farumasi y’imiti n’ibicuruzwa byoherezwa mu Burayi, Amerika y'Epfo, Uburasirazuba bwo hagati, Afurika, Aziya, n'ibindi bihugu birenga 60.
